Adelene Q. Perkins, EVP and Chief Business Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 10,000 shares at $10.63 ($106K) on 2007-06-15, disclosed to the SEC on 2007-06-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.63 | 1,000 | $11K | 10.0% |
| 2 | $10.64 | 8,000 | $85K | 80.0% |
| 3 | $10.65 | 1,000 | $11K | 10.0% |
| Total | $10.64 avg | 10,000 | $106K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |